Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Department of Health and Human Services
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
LEADER | 04997nam a2201621Ia 4500 | ||
---|---|---|---|
001 | 10-15585-MMWR-MM7102E1 | ||
008 | 220420s2022 CNT 000 0 und d | ||
020 | |a 01492195 (ISSN) | ||
245 | 1 | 0 | |a Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021 |
260 | 0 | |b Department of Health and Human Services |c 2022 | |
300 | |a 7 | ||
856 | |z View Fulltext in Publisher |u https://doi.org/10.15585/MMWR.MM7102E1 | ||
650 | 0 | 4 | |a adolescent |
650 | 0 | 4 | |a Adolescent |
650 | 0 | 4 | |a BNT162 Vaccine |
650 | 0 | 4 | |a case control study |
650 | 0 | 4 | |a Case-Control Studies |
650 | 0 | 4 | |a child |
650 | 0 | 4 | |a Child |
650 | 0 | 4 | |a complication |
650 | 0 | 4 | |a COVID-19 |
650 | 0 | 4 | |a epidemiology |
650 | 0 | 4 | |a female |
650 | 0 | 4 | |a Female |
650 | 0 | 4 | |a hospitalization |
650 | 0 | 4 | |a Hospitalization |
650 | 0 | 4 | |a human |
650 | 0 | 4 | |a Humans |
650 | 0 | 4 | |a immunology |
650 | 0 | 4 | |a male |
650 | 0 | 4 | |a Male |
650 | 0 | 4 | |a patient acuity |
650 | 0 | 4 | |a Patient Acuity |
650 | 0 | 4 | |a SARS-CoV-2 |
650 | 0 | 4 | |a systemic inflammatory response syndrome |
650 | 0 | 4 | |a Systemic Inflammatory Response Syndrome |
650 | 0 | 4 | |a United States |
650 | 0 | 4 | |a United States |
650 | 0 | 4 | |a vaccine |
650 | 0 | 4 | |a Vaccine Efficacy |
700 | 1 | 0 | |a Baida, N. |e author |
700 | 1 | 0 | |a Behl, S. |e author |
700 | 1 | 0 | |a Bennett, P.C. |e author |
700 | 1 | 0 | |a Berbert, L. |e author |
700 | 1 | 0 | |a Bhumbra, S.S. |e author |
700 | 1 | 0 | |a Bickford, M.M. |e author |
700 | 1 | 0 | |a Bline, K.E. |e author |
700 | 1 | 0 | |a Boom, J.A. |e author |
700 | 1 | 0 | |a Boutselis, B.J. |e author |
700 | 1 | 0 | |a Bowens, C. |e author |
700 | 1 | 0 | |a Bradford, T.T. |e author |
700 | 1 | 0 | |a Bruno, E.R. |e author |
700 | 1 | 0 | |a Cameron, M.A. |e author |
700 | 1 | 0 | |a Campbell, A.P. |e author |
700 | 1 | 0 | |a Carson, I.A. |e author |
700 | 1 | 0 | |a Chatani, B.M. |e author |
700 | 1 | 0 | |a Chen, S.R. |e author |
700 | 1 | 0 | |a Chiotos, K. |e author |
700 | 1 | 0 | |a Coates, B.M. |e author |
700 | 1 | 0 | |a Crane, K. |e author |
700 | 1 | 0 | |a Cullimore, M.L. |e author |
700 | 1 | 0 | |a Cvijanovich, N.Z. |e author |
700 | 1 | 0 | |a Dhanrajani, A. |e author |
700 | 1 | 0 | |a Douglas, R.L. |e author |
700 | 1 | 0 | |a Drapeau, N.M. |e author |
700 | 1 | 0 | |a Flori, H.R. |e author |
700 | 1 | 0 | |a Gaspers, M.G. |e author |
700 | 1 | 0 | |a Gertz, S.J. |e author |
700 | 1 | 0 | |a Goertzen, L.A. |e author |
700 | 1 | 0 | |a Golchha, M. |e author |
700 | 1 | 0 | |a Halasa, N.B. |e author |
700 | 1 | 0 | |a He, J. |e author |
700 | 1 | 0 | |a Heidemann, S.M. |e author |
700 | 1 | 0 | |a Hill, S.M. |e author |
700 | 1 | 0 | |a Hobbs, C.V. |e author |
700 | 1 | 0 | |a Hoody, L.A. |e author |
700 | 1 | 0 | |a Hume, J.R. |e author |
700 | 1 | 0 | |a Hussaini, L. |e author |
700 | 1 | 0 | |a Irby, K. |e author |
700 | 1 | 0 | |a Johnston, M.S. |e author |
700 | 1 | 0 | |a Kamidani, S. |e author |
700 | 1 | 0 | |a Kelley, C.P. |e author |
700 | 1 | 0 | |a Kietzman, A. |e author |
700 | 1 | 0 | |a Kong, M. |e author |
700 | 1 | 0 | |a Kucukak, S. |e author |
700 | 1 | 0 | |a Levy, E.R. |e author |
700 | 1 | 0 | |a Lionetti, G. |e author |
700 | 1 | 0 | |a Lockwood, J.M. |e author |
700 | 1 | 0 | |a Maamari, M. |e author |
700 | 1 | 0 | |a MacK, E.H. |e author |
700 | 1 | 0 | |a Maddux, A.B. |e author |
700 | 1 | 0 | |a Malloch, L. |e author |
700 | 1 | 0 | |a Martin, L. |e author |
700 | 1 | 0 | |a Michelson, K.N. |e author |
700 | 1 | 0 | |a Murcia-Montoya, J. |e author |
700 | 1 | 0 | |a Murdock, M. |e author |
700 | 1 | 0 | |a Navas, A.G. |e author |
700 | 1 | 0 | |a Newhams, M.M. |e author |
700 | 1 | 0 | |a Nofziger, R.A. |e author |
700 | 1 | 0 | |a Oates, J.N. |e author |
700 | 1 | 0 | |a Olson, S.M. |e author |
700 | 1 | 0 | |a Orzel, A.O. |e author |
700 | 1 | 0 | |a Overcoming COVID-19 Investigators |e author |
700 | 1 | 0 | |a Pannaraj, P.S. |e author |
700 | 1 | 0 | |a Patel, M.M. |e author |
700 | 1 | 0 | |a Patterson, K. |e author |
700 | 1 | 0 | |a Peralta, H. |e author |
700 | 1 | 0 | |a Phengchomphet, K. |e author |
700 | 1 | 0 | |a Port, E. |e author |
700 | 1 | 0 | |a Price, A.M. |e author |
700 | 1 | 0 | |a Randolph, A.G. |e author |
700 | 1 | 0 | |a Rinehart, V.H. |e author |
700 | 1 | 0 | |a Rohlfs, C.C. |e author |
700 | 1 | 0 | |a Rowan, C.M. |e author |
700 | 1 | 0 | |a Sahni, L.C. |e author |
700 | 1 | 0 | |a Sanders, C. |e author |
700 | 1 | 0 | |a Sanders, R.C. |e author |
700 | 1 | 0 | |a Schuster, J.E. |e author |
700 | 1 | 0 | |a Schwartz, S.P. |e author |
700 | 1 | 0 | |a Skura, A.L. |e author |
700 | 1 | 0 | |a Smallcomb, L. |e author |
700 | 1 | 0 | |a Smith, C. |e author |
700 | 1 | 0 | |a Staat, M.A. |e author |
700 | 1 | 0 | |a Stewart, L.S. |e author |
700 | 1 | 0 | |a Stumpf, M. |e author |
700 | 1 | 0 | |a Tarquinio, K.M. |e author |
700 | 1 | 0 | |a Tomcany, M.L. |e author |
700 | 1 | 0 | |a Twinem, N.A. |e author |
700 | 1 | 0 | |a Typpo, K.V. |e author |
700 | 1 | 0 | |a Villarreal-Chico, D. |e author |
700 | 1 | 0 | |a Wakefield, L.E. |e author |
700 | 1 | 0 | |a Walker, T.C. |e author |
700 | 1 | 0 | |a Weller, E. |e author |
700 | 1 | 0 | |a Wolfe, A. |e author |
700 | 1 | 0 | |a Yates, M. |e author |
700 | 1 | 0 | |a Zambrano, L.D. |e author |
700 | 1 | 0 | |a Zinter, M.S. |e author |
773 | |t Morbidity and Mortality Weekly Report |